Award Year / Program / Phase:2009 / SBIR / Phase I
Agency:HHS
Principal Investigator:Drazen Raucher
Award Amount:$139,375.00
Abstract:
DESCRIPTION (provided by applicant): Current treatment of solid tumors is limited by normal tissue tolerance, inherent tumor resistance to radiation or chemotherapy, and toxicity from systemic administration of antineoplastic agents. The result is a narrow
therapeutic index for most current… More